We make point-of-need-devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. These uncomplicated purpose-built devices provide users with the power to redefine their workflows by getting actionable answers at the point of need. Our devices are being used for critical applications across the globe in the life sciences and field forensic markets. 908 Devices is headquartered in the heart of Boston, where we research, design and manufacture innovative products based on high-pressure mass spectrometry (HPMS) and microfluidic separation technology. For more information, visit 908devices.com.
Location: Canada, Ontario, Boston
Employees: 51-200
Total raised: $57.2M
Founded date: 2012
Investors 7
Funding Rounds 4
| Date | Series | Amount | Investors |
| 30.04.2019 | Series E | $17.5M | - |
| 15.03.2017 | - | $20M | - |
| 06.05.2015 | Series C | $11.6M | - |
| 12.02.2013 | Series A | $8.1M | - |
Mentions in press and media 26
| Date | Title | Description |
| 19.12.2024 | Getinge and 908 Devices partner to enhance bioreactor capabilities for continuous monitoring of key cell culture parameters | Getinge and 908 Devices partner to enhance bioreactor capabilities for continuous monitoring of key cell culture parameters Thu, Dec 19, 2024 13:00 CET Report this content Today, Getinge and 908 Devices announce their collaboration to integ... |
| 14.09.2024 | The Future of Scent: Osmo's Scientific Advisory Board and Its Implications | In a world where technology and biology intertwine, Osmo is carving a niche in the realm of digital olfaction. The company recently announced the formation of its Scientific Advisory Board (SAB), a powerhouse of experts from diverse fields.... |
| 12.09.2024 | Osmo Announces Launch of Scientific Advisory Board | NEW YORK, Sept. 12, 2024 /PRNewswire/ -- The digital olfaction company, Osmo, today announced the formation of its Scientific Advisory Board (SAB) composed of leading experts in synthetic chemistry, analytical chemistry, artificial intellig... |
| 13.10.2022 | 908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis | REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40%\ 908 Devices, a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announc... |
| 04.11.2021 | Devices Reports Third Quarter 2021 Financial Results - Form 8-K | 908 Devices Reports Third Quarter 2021 Financial Results Sequential revenue growth of more than 50% compared to Q2 2021 Year-to-date product and service revenue growth of 36% compared to the same period of 2020 BOSTON, MA - November 4, 2021... |
| 04.08.2021 | 908 Devices : Expands Scientific Advisory Board, Creates Dedicated Proteomics Panel | 908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the forthcoming appointment of six new individuals to its Scientific Advisory Board (SAB),... |
| 04.08.2021 | 908 Devices : Devices Reports Second Quarter 2021 Financial Results and Raises 2021 Revenue Outlook (Form 8-K) | 908 Devices Reports Second Quarter 2021 Financial Results and Raises 2021 Revenue Outlook Increased 2021 revenue guidance projects 54% annual revenue growth at the midpoint of the range BOSTON, MA - August 4, 2021 - 908 Devices Inc. (Nasdaq... |
| 02.08.2021 | 908 Devices Expands Scientific Advisory Board, Creates Dedicated Proteomics Panel | Company appoints six new members to SAB to maximize the company’s impact in the proteomics domain 908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, announced the forthcomi... |
| 30.03.2021 | 908 DEVICES INC. 908 Devices : Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Revenue Outlook | BOSTON, March 30, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter and full ... |
| 30.04.2019 | Top startup news for today, Tuesday, April 30, 2019 | Good morning! Below are some of the top tech startup news stories for the last day of April 2019. Why is SoftBank’s $100 billion Vision Fund investing on unprofitable tech companies? Unlike other venture capital firms, SoftBank has become ... |
Show more